We are delighted to announce that Cambridge Bioscience has partnered with DIMA Biotech, a leading developer of innovative platforms used in the advancement of drug discovery and life-changing therapies within the BioPharma sector.
DIMA offer a wide range of pre-designed and validated antibody molecules for early-stage drug development, with over 5,000 lead antibodies targeting around 400 drug targets. Additonally, DIMA manufacture a wide selection of high-quality proteins and assays.
Cambridge Bioscience are pleased to distribute DIMA products in the UK and Ireland.
Learn more about DIMA or contact our DIMA specialists to discuss your project.
Published
26 Sep 2024